Focus on Melanoma meeting

Friday 14th October 2022

Organised by Professor Paul Lorigan

Registration for this event is now open

The Focus on Melanoma – October 2022 meeting has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credit(s) and The Royal College of Surgeons of England has awarded up to 5.5 CPD points.  The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) have awarded up to 8.5 CME points.

POSTERS:

Please submit your abstracts by 16th September 2022

(250 words maximum)

Please send posters to: mbridge@melanomafocus.org

Member Rates

Earlybird
(ended 18/09/22)
Late
registration
ConsultantOpen Form£149£219
Other Clinician/AHPOpen Form£109£159
Nurse/Medical StudentOpen Form£49£89

Non-Member Rates

Earlybird
(ended 18/09/22)
Late
registration
ConsultantOpen Form£199£269
Other Clinician/AHPOpen Form£139£189
Nurse/Medical StudentOpen Form£69£99
IndustryOpen Form£299£299

Programme

09:00-09:45

MSD SPONSORED BREAKFAST SYMPOSIUM:

Adjuvant treatment in melanoma, where are we now?

Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS
Foundation Trust

This promotional session is fully organised and funded by MSD. MSD products will be discussed at this meeting.

10:00-10:15

Welcome/Introductions and presentation to Simon Rodwell (ex CEO & Founder of Melanoma Focus)

Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus

10:15-10:25

Simon Rodwell, ex-CEO and Founder of Melanoma Focus

10:25-10:40

Melanoma Focus: Achievements and Plans

Dr Mark Harries and Susanna Daniels

10:40-11:30

Session 1:  What’s new in melanoma 2022 – the post pandemic era

Chair: Dr Matthew Wheater – Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust

10:40-11:10

Emerging treatments including research trends and challenges (inc Q+A)

Dr Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre

11:10-11:30

AMBLor: a prognostic biomarker for non-ulcerated AJCC stage I/II melanoma (inc Q+A)

Professor Penny Lovat, Professor of Cellular Dermatology and Oncology, Newcastle University; Chief Scientific Officer, AMLo Biosciences

11:30-12:00

Break

12:00-12:40

Session 2:  Merkel Cell Cancer, new treatments and guidelines

Chair: Professor Catherine Harwood, Consultant Dermatologist, Barts’ Health NHS Trust

Professor Jurgen Becker, Department of Translational Oncology, DKTK Essen, Dusseldorf

12:30-12:40

Q&A

12:40-13:10

Session 3:  Clinical dilemmas:  Sentinel node biopsy remains an important staging procedure? 

Chair: Professor Charlotte Proby, Professor of Dermatology and Honorary Consultant Dermatologist, Ninewells Hospital & Medical School

The case for:  Mr Howard Peach, Consultant Plastic and Reconstructive Surgeon, Leeds Teaching Hospitals NHS Trust

The case against: Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust

13:10-14:10

Lunch

14:10-14:55

The Professor Martin Gore CBE Memorial Lecture

Introduction – Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus

How treatments have changed and continued to evolve

Professor Claus Garbe, Head of Division of Dermato-oncology at Eberhard Karls University, Tuebingen and President European Association for Dermatology-Oncology

14:55-15:55

Session 4:  Sunbeds and skin cancer – the case for a ban?

Chair: Professor Paul Lorigan, Professor and Honorary Consultant in Medical Oncology, The Christie NHS Foundation Trust and the University of Manchester

14:05-15:05

Introduction- Professor Paul Lorigan

15:05-15:20

Sunbeds are carcinogenic and their outright ban in Australia

Professor Adele Green, Honorary Senior Scientist, QIMR Berghofer Medical Research Institute

15:20-15:35

The economic argument

Professor Katherine Payne, Professor of Health Economics, Centre Lead for Manchester Centre for Health Economics

15:35-15:50

Q&A

15:55-16:55

Session 5:  MDT:  The management of brain metastases

Chair: Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer
Centre and University College London Hospital

-Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust

-Mr Francesco Vergani, Consultant Neurosurgeon, King’s College Hospital NHS Foundation Trust

-Dr Matthew Wheater, Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust

-Jackie Hodgetts, Nurse Clinician in Melanoma, The Christie NHS Foundation Trust

16:55-17:00

Close

Professor Paul Lorigan and Dr Mark Harries